The FDA got it right when they approved TMS therapy for adolescent depression (kids aged 15 and older). TMS is one of the most effective treatments for resistant depression. The decision to approve this treatment for kids is an absolute game-changer and will save many young lives. This article describes the dramatic impact of the FDA’s approval and covers research that shows TMS for kids to be safe, well-tolerated, and effective.
Read MoreIf you have bipolar disorder, getting the right amount of sleep at the right time of day is absolutely critical in achieving and maintaining mood stability. Good sleep at night clearly exerts mood-stabilizing benefits. This article addresses several strategies for improving mood stability in bipolar disorder and discusses the tradeoffs faced in regulating your activities and schedule.
Read More2022 was the third year of The Psychiatry Resource. This article summarizes the milestones, surprises, and metrics over the past year, and includes goals and ideas for 2023 at PsychiatryResource.com.
Read MorePremenstrual Dysphoric Disorder (PMDD) sounds a lot like Premenstrual Syndrome (PMS), but is a far more extreme condition than PMS. If you have PMDD or know someone who does, the good news is that there are treatments that work.
Read MoreWhat is really happening behind the scenes at insurance companies to block patients from more expensive (and sometimes more effective) medical treatments? This article discusses the need for transparency and reform of the involvement of “hired gun” physicians in routine denials of medical coverage.
Read MoreSome medications are not friendly to your thyroid gland. You would expect that all doctors would be well-informed of the most likely culprits. So, how did Seroquel (quetiapine) slip through the cracks? This article takes a look at Seroquel (quetiapine) – one of the biggest troublemakers of thyroid function – and what can you do to protect yourself and the people you care about.
Read MoreWhile antidepressants often save lives, they can also result in very serious emotional and physical side effects from missed doses, reduced doses, or abrupt stopping. This article talks about the rarely discussed risk of acute depressive symptoms and the more widely known physical symptoms of serotonin withdrawal from switching or stopping your antidepressant medication.
Read MoreEven though depression rates for youth are rising, the FDA has only approved a few treatments for adolescent depression and has not yet approved TMS for adolescent depression. This article describes TMS for adolescents and covers research that shows TMS for kids to be safe, feasible, and likely effective.
Read MoreWhile some people can change their habits through sheer willpower, many people need a source of motivation or energy to make meaningful change. This is especially true for people who experience depression. This article discusses depressive habits and strategies for changing them so that treatment for depression can be more effective and durable.
Read MoreTranscranial Magnetic Stimulation (TMS) therapy, one of the most effective treatments for major depression, has been FDA approved for adults for 14 years. The FDA has not yet approved TMS for adolescent depression even though they approved a TMS device for migraine headaches in children. This article reviews research that shows TMS for adolescent depression to be safe, feasible, and effective.
Read More2021 was the second year of The Psychiatry Resource. This article provides a recap of the highs and lows. It shows what things stayed the same, which areas required change, and where priorities shifted at PsychiatryResource.com.
Read MoreTranscranial Magnetic Stimulation (TMS) therapy is one of the newest and most effective treatments for major depression, especially treatment-resistant depression. This article reviews recent research that supports Stanford’s revolutionary approach, which may improve the effectiveness and accessibility of TMS for depression.
Read MoreVagus nerve stimulation (VNS) has been available for decades for the treatment of seizures and more recently for the treatment of depression. This article explains the theory behind how VNS works, its outcomes for bipolar and unipolar depression and the potential downsides of the treatment.
Read MoreThe Covid-19 pandemic has fueled racism directed at Asian American Pacific Islander (AAPI) people, and people of color continue to battle against structural racism, cultural appropriation and cultural insensitivity. This article addresses the reasons why Kung Fu Psychiatry is changing its name to The Psychiatry Resource.
Read More7 million Christians in the US experience major depression each year. While attendance of religious services might be protective, it is not protective enough. This article discusses research on Christians with depression, the impact of stigma and how I calculated the number of depressed Christians.
Read MoreIn 2020, I launched my Kung Fu Psychiatry blog, published 43 articles and 31 book reviews and spent more money than my blog earned. This article addresses the highs, the lows and the lessons learned from my first year blogging on KungFuPsychiatry.com.
Read MoreThe Strengthening Behavioral Health Parity Act (SBHPA) was a major step toward mental health parity in the US. Before its passage, many Americans, especially those with ERISA-based health plans, were not protected by federal and state mental health parity laws. This article describes the history of mental health parity and what people can do to advocate for themselves.
Read MoreSupportive psychotherapy is commonly used as a comparison intervention or “treatment as usual” in mental health research studies. While it is often expected by the scientific elite to be less effective than newer, manualized therapies, it has been proven to be an effective intervention for many conditions. This article covers basic approaches in supportive psychotherapy and who might benefit from the treatment.
Read More
